Nose-to-brain siRNA delivery by PEI/PPI-based nanoparticles reduces α-synuclein expression in a Parkinson's disease mouse model.

Molecular therapy. Nucleic acids

Feja M, Drath I, Weiß S, Ewe A, Gericke B, Outeiro TF, Stefanis L, Aigner A, Richter F. Nose-to-brain siRNA delivery by PEI/PPI-based nanoparticles reduces α-synuclein expression in a Parkinson's disease mouse model. Mol Ther Nucleic Acids. 2025 Sep 09; 36(3):102671.

2025
https://researcherprofiles.org/profile/679823246
40978531

Feja M, Drath I, Weiß S, Ewe A, Gericke B, Outeiro TF, Stefanis L, Aigner A, Richter F